A group of UCL Mental Health Masters students summarise an RCT on the clinical and cost-effectiveness of the MARQUE intervention (Managing Agitation and Raising Quality of Life) for agitation in people with dementia in care homes.
[read the full story...]
A group of UCL Masters students summarise an RCT (the PAXPD trial) of iCBT for panic disorder, which compared guided (via real-time video sessions) with unguided self-help treatment and a waitlist control.
[read the full story...]
Pooky Knightsmith looks at the Education Endowment Foundation report on Teacher Observation, which concludes that structured lesson observation programmes have no benefits above existing programmes of peer observation.
[read the full story...]
Vicky Carlisle summarises a promising recent RCT on the efficacy and cost-effectiveness of an adjunctive personalised psychosocial intervention in treatment-resistant maintenance opioid agonist therapy.
[read the full story...]
Jodi Rintelman writes her debut elf blog on the first randomised controlled trial on the efficacy and safety of intranasal esketamine as an adjunctive treatment to antidepressants for treatment-resistant depression.
[read the full story...]
Maria Loades explores a randomised controlled trial of people with depression, which looks at the impact and change of attitudes towards internet interventions.
[read the full story...]
Saoirse Finn writes a #LetsTalkMentalHealthII blog about group singing for women with postnatal depression.
[read the full story...]
David Shiers and Peter Byrne summarise the new SCIMITAR+ trial out today in The Lancet Psychiatry, which evaluates a bespoke smoking cessation intervention for people with severe mental illness.
[read the full story...]
Robyn Murphy summarises an RCT that compares the effectiveness and cost-effectiveness of an intensive community supported discharge service versus treatment as usual for adolescents with psychiatric emergencies.
[read the full story...]
Keir Harding prepares for the #BIGSPD19 conference by reading Mike Crawford et al’s recent RCT on the clinical effectiveness and cost-effectiveness of lamotrigine in borderline personality disorder.
[read the full story...]
